ReShape taps Allergan vet Bandy for CEO | Personnel Moves, April 3 2019

ReShape Lifesciences (NSDQ:RSLS) said last week that it named Allergan (NYSE: AGN) veteran Barton Bandy to replace Dan Gladney in the corner office, effective April 1. Gladney, who announced his retirement in January, is staying on as chairman. Bandy spent a decade at Inamed until its $3.2 billion purchase by Allergan in 2005. “I am very pleased to welcome Bart to the ReShape team. His experience and success – particularly with the Lap-Band business at Inamed and Allergan – in addition to his leadership track record since then make Bart the perfect next leader for ReShape,” Gladney said in prepared remarks. “I would like to thank the ReShape team for the hard work and dedication during my time as CEO and I look forward to assisting in a smooth transition and continuing on as a dedicated chairman of the board.” “This is a very exciting time to be joining ReShape. My experience leading and building medical device organizations and the company’s strategic shift to the proven Lap-Band product, which I know very well, present immediate growth opportunities,” Bandy added. “It is also an incredibly exciting time to see the next-generation, revolutionary ReShape Vest through clinical studies to commercialization. I am thrilled to be part of ReShape Lifesciences and to help drive its future success.”  Alcon lures HP CFO Stonesifer as finance chief Novartis (NYSE:NVS) eye business Alcon said it lured Hewlett Packard HPE CFO Ti...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Featured Alcon Bio-Rad Dept. of Health & Human Services (HHS) ExsoMed FDA iCad Inc. McKesson Novartis Personnel Moves polarityte ReShape Lifesciences Stryker Source Type: news